Dr. Rahimi received his B.S. degree in Biology and Psychology from the University of Maryland, Baltimore County and his M.S. and Ph.D. degrees in Tumor Biology from Georgetown University. He completed a post-doctoral fellowship at the National Cancer Institute (NCI) in 2012 before becoming a NCI/FDA Interagency Oncology Task Force (IOTF) fellow. In 2014 Dr. Rahimi became a Senior Staff Fellow – Research/Reviewer in OBP where he divided his time between investigating cellular processes in the production and regulation of growth and developmental factors and conducting product quality assessments for biotechnology products.
In his current position, Dr. Rahimi provides authoritative technical guidance to the multidisciplinary assessment team and the assigned primary product quality assessor with a focus on critical pharmaceutical quality attributes and their relevance to safety and efficacy of the drug. He also identifies and addresses critical pharmaceutical manufacturing issues to facilitate product-specific inspections or enforcement actions and serves as a coach and facilitator in coordinating team initiatives, policy implementation, and consensus building.